ExodusPoint Capital Management, LP

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1736225 NEW YORK, NY

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$16,752,562

+$7,168,213 QoQ

Shares Held

224,927

+79.5% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#97

of 462 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. BBIO ranks #2 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc. This page	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,752,562	224,927	+79.5%	Shares	Sole	2026-08-14
2025-12-31	$9,584,349	125,302	+311.8%	Shares	Sole	2026-02-17
2025-09-30	$1,580,430	30,428	-84.0%	Shares	Sole	2025-11-14
2025-06-30	$8,228,683	190,567	+438.6%	Shares	Sole	2025-08-13
2025-03-31	$1,223,052	35,379	+137.6%	Shares	Sole	2025-05-14
2024-06-30	$377,163	14,890	+17.9%	Shares	Sole	2024-08-13
2023-03-31	$209,305	12,624	-92.3%	Shares	Sole	2023-05-11
2022-09-30	$1,620,031	162,981	-31.0%	Shares	Other	2022-11-10
2022-06-30	$2,143,896	236,112	+155.9%	Shares	Other	2022-08-22
2022-03-31	$936,418	92,258	+249.6%	Shares	Other	2022-05-13
2021-09-30	$1,237,039	26,393	+142.4%	Shares	Other	2021-11-15
2021-03-31	$670,762	10,889	—	Shares	Other	2021-05-17
No filing history on record for this holder in this stock.